Research News

Peanut immunotherapy provides long lasting suppression of allergy, finds study

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3937 (Published 18 August 2017) Cite this as: BMJ 2017;358:j3937
  1. Susan Mayor
  1. London

Probiotic and peanut oral immunotherapy provides long lasting suppression of peanut allergy in children that continues for at least four years after stopping treatment, reports a long term follow-up study that investigated this approach.1

“Combined probiotic and peanut oral immunotherapy was associated with long lasting peanut tolerance four years after stopping treatment,” said the researchers, led by Mimi Tang, from the Royal Children’s Hospital in Melbourne, Australia.

Two thirds of the study participants who were given probiotic and peanut immunotherapy were able to continue eating peanut products regularly, with more than half eating …

View Full Text

Sign in

Log in through your institution

Subscribe